Medications & Supplements/Prescription Drugs

American Health Packaging Bupropion XL 150 mg Recalled for Fast Dissolution

Agency Publication Date: July 8, 2024

Summary

Amerisource Health Services LLC is recalling 2,484 cartons of bupropion hydrochloride extended-release tablets (generic Wellbutrin XL), 150 mg strength, distributed by American Health Packaging. The recall was issued because the tablets are dissolving faster than required safety and quality limits. If you have health concerns regarding your medication, you should contact your doctor or pharmacist for guidance.

Risk

When extended-release medication dissolves too quickly, the drug may be released into the body faster than intended, which could potentially cause side effects or affect the treatment's success.

What You Should Do

This recall involves bupropion hydrochloride extended-release tablets USP (XL) Once-Daily, 150 mg, sold in 100-tablet cartons (10 x 10 blister packs) under NDC 60687-782-01.
Identify your medication by checking the package for lot number 1017343 with an expiration date of 12/31/2025.
If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact Amerisource Health Services LLC for further instructions.
Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls for more information.

Your Remedy Options

You have 2 options:

Option 1: Full Refund

How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund

Option 2: Dispose of Product

How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: buPROPion Hydrochloride Extended-release Tablets USP (XL) (150 mg, 100 Tablets)by American Health Packaging

Variants: 150 mg, Extended-release, Once-Daily

Lot Numbers:

1017343 (Exp. 12/31/2025)

NDC:

60687-782-01

Distributed by American Health Packaging, Columbus, Ohio. Recall #: D-0590-2024.

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 94891

Status: Active

Manufacturer: Amerisource Health Services LLC

Sold By: Pharmacies; Healthcare facilities

Manufactured In: United States

Units Affected: 2,484 cartons

Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

What You Should Do

This recall involves bupropion hydrochloride extended-release tablets USP (XL) Once-Daily, 150 mg, sold in 100-tablet cartons (10 x 10 blister packs) under NDC 60687-782-01.

Identify your medication by checking the package for lot number 1017343 with an expiration date of 12/31/2025.

If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact Amerisource Health Services LLC for further instructions.

Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls for more information.